SCHEMBL13437154

SCHEMBL13437154

O=C(NC1c2ccccc2-c2c(-c3nc4ccncc4[nH]3)cccc21)c1cccc2cnccc12

nearest known ligand 0.76

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 5/20 0.76
SMN1; SMN2 Q16637 2/20 0.42
PDE5A O76074 3/20 0.41
HPSE Q9Y251 1/20 0.39
FGFR1 P11362 2/20 0.38
FLT1 P17948 2/20 0.38
METAP2 P50579 1/20 0.37
METAP1 P53582 1/20 0.37
KDM4E B2RXH2 1/20 0.37
RAB9A P51151 1/20 0.37
PREP P48147 2/20 0.36
ADORA3 P0DMS8 1/20 0.36
DPP7 Q9UHL4 1/20 0.36
GHSR Q92847 1/20 0.36
RET P07949 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13437153 0.90 HSP90AB1 (0.70) HSP90AB1SMN1; SMN2PDE5AHPSEFGFR1
SCHEMBL12431199 0.88 HSP90AB1 (0.73) HSP90AB1SMN1; SMN2PDE5AHPSEFGFR1
SCHEMBL13437143 0.88 HSP90AB1 (0.85) HSP90AB1SMN1; SMN2PDE5AHPSEFGFR1
SCHEMBL12430436 0.87 HSP90AB1 (0.70) HSP90AB1SMN1; SMN2PDE5AHPSEFGFR1
SCHEMBL12431194 0.87 HSP90AB1 (0.79) HSP90AB1SMN1; SMN2PDE5AHPSEFGFR1
SCHEMBL13437166 0.87 HSP90AB1 (1.00) HSP90AB1SMN1; SMN2PDE5AHPSEMETAP2
SCHEMBL13437212 0.86 HSP90AB1 (0.78) HSP90AB1SMN1; SMN2PDE5AHPSEMETAP2
SCHEMBL12430894 0.86 HSP90AB1 (0.78) HSP90AB1SMN1; SMN2PDE5AHPSEMETAP2
SCHEMBL12430906 0.86 HSP90AB1 (0.78) HSP90AB1SMN1; SMN2PDE5AHPSEFGFR1
SCHEMBL13437206 0.86 HSP90AB1 (0.78) HSP90AB1SMN1; SMN2PDE5AHPSEFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7674795-B2 Fluorene derivatives, composition containing said derivatives and the use thereof AVENTIS PHARMA SA (FR) 2010-03-09 US disclosed
US-7674795-B2 Fluorene derivatives, composition containing said derivatives and the use thereof AVENTIS PHARMA SA (FR) 2010-03-09 US disclosed
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof AVENTIS PHARMA S.A. (FR) 2008-06-26 US disclosed
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof AVENTIS PHARMA S.A. (FR) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof HSP90B1, HSP90AB1, HSP90AA1 HSP90AB1 2/4885SMN1; SMN2 1564/4885PDE5A 2779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.